טוען...

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer

Lung cancer is one of the leading causes of cancer mortality worldwide. The therapeutic effect of chemotherapy is limited due to the resistance of cancer cells, which remains a challenge in cancer therapeutics. In this work, we found that flap endonuclease 1 (FEN1) is overexpressed in lung cancer ce...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Mol Oncol
Main Authors: He, Lingfeng, Luo, Libo, Zhu, Hong, Yang, Huan, Zhang, Yilan, Wu, Huan, Sun, Hongfang, Jiang, Feng, Kathera, Chandra S., Liu, Lingjie, Zhuang, Ziheng, Chen, Haoyan, Pan, Feiyan, Hu, Zhigang, Zhang, Jing, Guo, Zhigang
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley and Sons Inc. 2017
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5467497/
https://ncbi.nlm.nih.gov/pubmed/28371273
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12058
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!